Up And Down The Ladder… Job Changes

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone? And here is our regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that MyoKardia hired Jonathan Fox as chief medical officer. He previously was vp of clinical development at AstraZeneca; sr director, clinical cardiovascular research at Merck; and director of clinical pharmacology at SmithKline Beecham. He also served as an industry rep on the FDA Cardiovascular and Renal Drug Products Advisory Committee. Novo Nordisk promoted Andy Ajello to sr vp US diabetes sales; Novo Nordisk promoted Camille Lee to sr vp US diabetes marketing; Novo Nordisk promoted Alan Moses to sr vp global chief medical officer; Novo Nordisk promoted Anne Phillips to sr vp US clinical, medical & regulatory; BrainStorm Cell Therapeutics named Alon Natanson as ceo; Pantheon named Ageel Farmi as exec vp of global R&D; Juventas Therapeutics hired Paul Resnick as vp of business development; Novella Clinical hired Karen Kelso as director of regulatory affairs; Metrics promoted Thomas “Brad” Gold to vp of pharmaceutical d...
Source: Pharmalot - Category: Pharma Commentators Authors: Tags: Uncategorized BrainStorm Cell Therapeutics Clondalkin Comprehensive Clinical Development Cytovance Juventas Therapeutics Metrics MyoKardia Novella Clinical Novo Nordisk Pantheon Questcor Pharmaceuticals Synteract Source Type: blogs